Dyspnea in Post-COVID Syndrome following Mild Acute COVID-19 Infections: Potential Causes and Consequences for a Therapeutic Approach DOI Creative Commons
Klaus Wirth, Carmen Scheibenbogen

Medicina, Год журнала: 2022, Номер 58(3), С. 419 - 419

Опубликована: Март 12, 2022

Dyspnea, shortness of breath, and chest pain are frequent symptoms post-COVID syndrome (PCS). These unrelated to organ damage in most patients after mild acute COVID infection. Hyperventilation has been identified as a cause exercise-induced dyspnea PCS. Since there is broad overlap symptomatology with myalgic encephalomyelitis/chronic fatigue (ME/CFS), causes for potential consequences can be deduced by stringent application assumptions made ME/CFS our recent review papers. One the first stimuli respiration exercise caused metabolic feedback via skeletal muscle afferents. PCS, which occurs early on during exercise, arise from combined disturbance poor energetic situation autonomic dysfunction (overshooting respiratory response), both found ME/CFS. The exaggerated response aggravating does not only limit ability but further impairs muscular situation: one buffering mechanisms alkalosis proton shift intracellular extracellular space sodium–proton-exchanger subtype 1 (NHE1), thereby loading cells sodium. This adds two other sodium already operative, namely glycolytic metabolism (intracellular acidosis) impaired Na+/K+ATPase activity. High unfavorable effects mitochondrial calcium sodium–calcium-exchangers (NCX). Mitochondrial overload high reversing transport mode NCX import key driver chronification. Prevention hyperventilation therapeutic keeping below threshold where occurs.

Язык: Английский

Long COVID: major findings, mechanisms and recommendations DOI Open Access
Hannah Davis, Lisa McCorkell, Julia Moore Vogel

и другие.

Nature Reviews Microbiology, Год журнала: 2023, Номер 21(3), С. 133 - 146

Опубликована: Янв. 13, 2023

Язык: Английский

Процитировано

2862

Long covid—mechanisms, risk factors, and management DOI Open Access

Harry Crook,

Sanara Raza,

Joseph Nowell

и другие.

BMJ, Год журнала: 2021, Номер unknown, С. n1648 - n1648

Опубликована: Июль 26, 2021

Since its emergence in Wuhan, China, covid-19 has spread and had a profound effect on the lives health of people around globe. As 4 July 2021, more than 183 million confirmed cases been recorded worldwide, 3.97 deaths. Recent evidence shown that range persistent symptoms can remain long after acute SARS-CoV-2 infection, this condition is now coined covid by recognized research institutes. Studies have affect whole spectrum with covid-19, from those very mild disease to most severe forms. Like involve multiple organs many systems including, but not limited to, respiratory, cardiovascular, neurological, gastrointestinal, musculoskeletal systems. The include fatigue, dyspnea, cardiac abnormalities, cognitive impairment, sleep disturbances, post-traumatic stress disorder, muscle pain, concentration problems, headache. This review summarizes studies term effects hospitalized non-hospitalized patients describes they endure. Risk factors for possible therapeutic options are also discussed.

Язык: Английский

Процитировано

1486

Pathophysiology and mechanism of long COVID: a comprehensive review DOI
Diego Castanares‐Zapatero, Patrice Chalon, Laurence Kohn

и другие.

Annals of Medicine, Год журнала: 2022, Номер 54(1), С. 1473 - 1487

Опубликована: Май 20, 2022

After almost 2 years of fighting against SARS-CoV-2 pandemic, the number patients enduring persistent symptoms long after acute infection is a matter concern. This set was referred to as "long COVID", and it defined more recently "Post COVID-19 condition" by World health Organization (WHO). Although studies have revealed that COVID can manifest whatever severity inaugural illness, underlying pathophysiology still enigmatic.To conduct comprehensive review address putative persisting COVID.We searched 11 bibliographic databases (Cochrane Library, JBI EBP Database, Medline, Embase, PsycInfo, CINHAL, Ovid Nursing Journals@Ovid, SciLit, EuropePMC, CoronaCentral). We selected put forward hypotheses on pathophysiology, well those encompassed in their research investigation.A total 98 articles were included systematic review, 54 which exclusively addressed while 44 involved patients. Studies displayed heterogeneity with respect initial timing analysis, or presence control group. likely results from long-term organ damage due acute-phase infection, specific mechanisms following illness could contribute later possibly affecting many organs. As such, autonomic nervous system account for without clear evidence damage. Immune dysregulation, auto-immunity, endothelial dysfunction, occult viral persistence, coagulation activation are main pathophysiological so far.Evidence why occur limited, available heterogeneous. Apart damage, hints suggest be symptoms. KEY MESSAGESLong-COVID multisystem disease develops regardless severity. Its clinical spectrum comprises wide range symptoms.The its unclear. phase accounts symptoms, long-lasting inflammatory been proposed, well.Existing involving Long-COVID highly heterogeneous, they include various levels different time frame well.

Язык: Английский

Процитировано

471

Unexplained post-acute infection syndromes DOI Open Access
Jan Choutka,

Viraj Jansari,

Mady Hornig

и другие.

Nature Medicine, Год журнала: 2022, Номер 28(5), С. 911 - 923

Опубликована: Май 1, 2022

Язык: Английский

Процитировано

434

Psychiatric and neuropsychiatric sequelae of COVID-19 – A systematic review DOI Creative Commons

Thor Mertz Schou,

Sâmia R.L. Joca, Gregers Wegener

и другие.

Brain Behavior and Immunity, Год журнала: 2021, Номер 97, С. 328 - 348

Опубликована: Июль 30, 2021

It has become evident that coronavirus disease 2019 (COVID-19) a multi-organ pathology includes the brain and nervous system. Several studies have also reported acute psychiatric symptoms in COVID-19 patients. An increasing number of are suggesting deficits may persist after recovery from primary infection. In current systematic review, we provide an overview available evidence supply information on potential risk factors underlying biological mechanisms behind such sequelae. We performed search for sequelae patients using databases PubMed Embase. Included all contained follow-up period provided quantitative measures mental health. The was June 4th 2021. 1725 unique were identified. Of these, 66 met inclusion criteria included. Time to ranged immediately hospital discharge up 7 months discharge, participants spanned 3 266,586 participants. Forty anxiety and/or depression, 20 symptoms- or diagnoses post-traumatic stress disorder (PTSD), 27 cognitive deficits, 32 articles found fatigue at follow-up, sleep disturbances 23 studies. Highlighted severity, duration symptoms, female sex. One study showed abnormalities correlating with several inflammatory markers correlate symptoms. Overall, results this review suggest survivors but generally improve over time.

Язык: Английский

Процитировано

372

A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications DOI Creative Commons
Douglas B. Kell,

Gert Jacobus Laubscher,

Etheresia Pretorius

и другие.

Biochemical Journal, Год журнала: 2022, Номер 479(4), С. 537 - 559

Опубликована: Фев. 23, 2022

Post-acute sequelae of COVID (PASC), usually referred to as ‘Long COVID’ (a phenotype COVID-19), is a relatively frequent consequence SARS-CoV-2 infection, in which symptoms such breathlessness, fatigue, ‘brain fog’, tissue damage, inflammation, and coagulopathies (dysfunctions the blood coagulation system) persist long after initial infection. It bears similarities other post-viral syndromes, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Many regulatory health bodies still do not recognize this separate disease entity, refer it under broad terminology ‘COVID’, although its demographics are quite different from those acute COVID-19. A few years ago, we discovered that fibrinogen can clot into an anomalous ‘amyloid’ form fibrin (like β-rich amyloids prions) resistant proteolysis (fibrinolysis). The result, strongly manifested platelet-poor plasma (PPP) individuals with Long COVID, extensive amyloid microclots persist, entrap proteins, may lead production various autoantibodies. These more-or-less easily measured PPP stain thioflavin T simple fluorescence microscope. Although multifarious, here argue ability these (fibrinaloids) block up capillaries, thus limit passage red cells hence O2 exchange, actually underpin majority symptoms. Consistent this, preliminary report, has been shown suitable closely monitored ‘triple’ anticoagulant therapy leads removal also removes Fibrin represent novel potentially important target for both understanding treatment related disorders.

Язык: Английский

Процитировано

217

TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases DOI Creative Commons
Miao Zhang, Yueming Ma,

Xianglu Ye

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2023, Номер 8(1)

Опубликована: Июль 5, 2023

Abstract Transient receptor potential (TRP) channels are sensors for a variety of cellular and environmental signals. Mammals express total 28 different TRP channel proteins, which can be divided into seven subfamilies based on amino acid sequence homology: TRPA (Ankyrin), TRPC (Canonical), TRPM (Melastatin), TRPML (Mucolipin), TRPN (NO-mechano-potential, NOMP), TRPP (Polycystin), TRPV (Vanilloid). They class ion found in numerous tissues cell types permeable to wide range cations such as Ca 2+ , Mg Na + K others. responsible various sensory responses including heat, cold, pain, stress, vision taste activated by number stimuli. Their predominantly location the surface, their interaction with physiological signaling pathways, unique crystal structure make TRPs attractive drug targets implicate them treatment diseases. Here, we review history discovery, summarize structures functions family, highlight current understanding role pathogenesis human disease. Most importantly, describe channel-related therapeutic interventions diseases limitations targeting clinical applications.

Язык: Английский

Процитировано

214

Chronic Fatigue and Postexertional Malaise in People Living With Long COVID: An Observational Study DOI Open Access
Rosie Twomey,

Jessica DeMars,

Kelli Franklin

и другие.

Physical Therapy, Год журнала: 2022, Номер 102(4)

Опубликована: Янв. 8, 2022

People living with long COVID describe a high symptom burden, and more detailed assessment is needed to inform rehabilitation recommendations. The objectives were use validated questionnaires measure the severity of fatigue compare this normative data thresholds for clinical relevance in other diseases; impact postexertional malaise (PEM); assess symptoms dysfunctional breathing, self-reported physical activity, health-related quality life.

Язык: Английский

Процитировано

197

ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature DOI Creative Commons
Anthony L. Komaroff, W. Ian Lipkin

Frontiers in Medicine, Год журнала: 2023, Номер 10

Опубликована: Июнь 2, 2023

Some patients remain unwell for months after "recovering" from acute COVID-19. They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance other symptoms that greatly interfere with their ability to function can leave some people housebound disabled. The illness (Long COVID) is similar myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) as well persisting illnesses follow a wide variety of infectious agents following major traumatic injury. Together, these are projected cost the U.S. trillions dollars. In this review, we first compare ME/CFS Long COVID, noting considerable similarities few differences. We then in extensive detail underlying pathophysiology two conditions, focusing on abnormalities central autonomic nervous system, lungs, heart, vasculature, immune gut microbiome, energy metabolism redox balance. This comparison highlights how strong evidence each abnormality, illness, helps set priorities future investigation. review provides current road map literature biology both illnesses.

Язык: Английский

Процитировано

188

Proposed subtypes of post‐COVID‐19 syndrome (or long‐COVID) and their respective potential therapies DOI Creative Commons
Shin Jie Yong, Shiliang Liu

Reviews in Medical Virology, Год журнала: 2021, Номер 32(4)

Опубликована: Дек. 9, 2021

Summary The effects of coronavirus disease 2019 (COVID‐19), a highly transmissible infectious respiratory that has initiated an ongoing pandemic since early 2020, do not always end in the acute phase. Depending on study referred, about 10%–30% (or more) COVID‐19 survivors may develop long‐COVID or post‐COVID‐19 syndrome (PCS), characterised by persistent symptoms (most commonly fatigue, dyspnoea, and cognitive impairments) lasting for 3 months more after COVID‐19. While pathophysiological mechanisms PCS have been extensively described elsewhere, subtypes not. Owing to its multifaceted nature, this review proposes characterises six based existing literature. are non‐severe multi‐organ sequelae (NSC‐MOS), pulmonary fibrosis (PFS), myalgic encephalomyelitis chronic fatigue (ME/CFS), postural orthostatic tachycardia (POTS), post‐intensive care (PICS) medical clinical (MCS). Original studies supporting each these documented review, as well their respective potential interventions. Ultimately, subtyping proposed herein aims provide better clarity current understanding PCS.

Язык: Английский

Процитировано

140